PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.18%
Net income growth at 50-75% of TRAW's 80.65%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-29.56%
Both reduce yoy D&A, with TRAW at -3.85%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
78.42%
Less SBC growth vs. TRAW's 10279.61%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
355.10%
Less working capital growth vs. TRAW's 1059.23%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
Lower AP growth vs. TRAW's 669.74%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
781.33%
Growth well above TRAW's 70.67%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-0.56%
Negative yoy while TRAW is 922.42%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
75.47%
Operating cash flow growth below 50% of TRAW's 775.45%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.